Remedium Co. Ltd. is a biotechnology company offering customized solutions in fields such as molecular biology, pharmacology, embryology, bioengineering, microbiology, and bioinformatics as well as in preclinical studies and research-development (R&D) programs.
Planning of the services in the company is conducted by consultants working in R&D programs for more than 20 years. Laboratory services are conducted by qualified personnel.
Since its foundation, Remedium has aimed to provide expertise and scientific knowledge to offer a customized, confidential, interactive, and quality service to customers.
While optimizing budgets, it also aims to meet customer expectations with high-level technical solutions.
Remedium company also aims to become a preferable partner in your projects by enabling you to save time and to reduce operating costs.
Remedium Diagnostic and Treatment Products Co. Ltd. is a
start-upcompany founded by Gülperi Öktem in 2018 in Ege Technopark Technology Development Zone.
Founder, General Manager Ege Üniversitesi Tıp Fakültesi Histoloji ve Embriyoloji AbD. Ege Üniversitesi Sağlık Bilimleri Enstitüsü Kök Hücre Anabilim Dalı
She was born in Ankara in 1971. She attended Dokuz Eylul University, Faculty of Medicine between 1989-1995. She had her residency in Ege University Faculty of Medicine, Department of Histology and Embryology between 1999-2002. She worked at University of Helsinki Haartman Institute in 2000. After being declared Assistant Professor of Ege University Faculty of Medicine, Department of Histology and Embryology in 2004, she was awarded the title of Associate Professor in 2007 and Professor in 2013. In 2008 and 2014 respectively, she worked at the Harvard University Beth Israel Deaconess Medical Center in creating a cancer treatment model using Cancer Stem Cell and the siRNA technology. In 2014, she completed her “Doctorate” Degree at Ege University Health Sciences Institute, Stem Cell Department. After completing her doctorate degree, she was awarded the title of Head of Department in Stem Cell Department and still holds office there. She is conducting research on issues such as Stem Cell, Cancer Stem Cell, Developmental Biology, Regenerative Medicine, Monoclonal Antibody technologies. She has many published articles and book chapters on these issues. In addition to membership to several scientific institutions, she is a board member and a referee in scientific journals. She is married and has a daughter.